UMB Bank n.a. Has $2.86 Million Holdings in McKesson Co. (NYSE:MCK)

UMB Bank n.a. lessened its stake in shares of McKesson Co. (NYSE:MCK - Free Report) by 23.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,250 shares of the company's stock after selling 1,316 shares during the quarter. UMB Bank n.a.'s holdings in McKesson were worth $2,860,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in MCK. Brighton Jones LLC increased its stake in shares of McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company's stock valued at $1,438,000 after acquiring an additional 798 shares during the period. Apollon Wealth Management LLC increased its stake in shares of McKesson by 2.9% during the fourth quarter. Apollon Wealth Management LLC now owns 7,794 shares of the company's stock valued at $4,442,000 after acquiring an additional 218 shares during the period. Kingsview Wealth Management LLC increased its stake in shares of McKesson by 1.2% during the fourth quarter. Kingsview Wealth Management LLC now owns 3,123 shares of the company's stock valued at $1,780,000 after acquiring an additional 37 shares during the period. Entropy Technologies LP acquired a new position in shares of McKesson during the fourth quarter valued at approximately $2,300,000. Finally, AlphaStar Capital Management LLC acquired a new position in shares of McKesson during the fourth quarter valued at approximately $203,000. Institutional investors and hedge funds own 85.07% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Morgan Stanley raised their price objective on shares of McKesson from $745.00 to $770.00 and gave the company an "overweight" rating in a research note on Wednesday. UBS Group lifted their price target on shares of McKesson from $708.00 to $805.00 and gave the stock a "buy" rating in a research report on Tuesday, April 29th. Bank of America lifted their price target on shares of McKesson from $755.00 to $800.00 and gave the stock a "buy" rating in a research report on Friday, May 9th. Mizuho lifted their price target on shares of McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a research report on Thursday, April 3rd. Finally, Wall Street Zen upgraded shares of McKesson from a "buy" rating to a "strong-buy" rating in a research report on Friday, May 30th. Three analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $694.38.

Insider Buying and Selling at McKesson

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 543 shares of McKesson stock in a transaction on Monday, May 19th. The shares were sold at an average price of $726.51, for a total transaction of $394,494.93. Following the completion of the sale, the chief accounting officer now owns 1,972 shares of the company's stock, valued at $1,432,677.72. This trade represents a 21.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Thomas L. Rodgers sold 510 shares of McKesson stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $717.91, for a total transaction of $366,134.10. Following the sale, the executive vice president now directly owns 5,435 shares of the company's stock, valued at $3,901,840.85. This trade represents a 8.58% decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,117 shares of company stock valued at $23,526,451 in the last quarter. Company insiders own 0.11% of the company's stock.

McKesson Price Performance

NYSE MCK traded up $11.89 on Wednesday, hitting $716.75. 782,971 shares of the stock were exchanged, compared to its average volume of 919,797. McKesson Co. has a 52-week low of $464.42 and a 52-week high of $731.00. The company has a market capitalization of $89.67 billion, a price-to-earnings ratio of 32.82, a P/E/G ratio of 1.29 and a beta of 0.49. The company's 50-day moving average price is $700.42 and its two-hundred day moving average price is $642.88.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $10.12 earnings per share for the quarter, topping the consensus estimate of $9.83 by $0.29. McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. The firm had revenue of $90.82 billion for the quarter, compared to analysts' expectations of $94 billion. During the same period in the previous year, the company posted $6.18 EPS. The company's quarterly revenue was up 18.9% compared to the same quarter last year. Equities analysts predict that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 1st. Shareholders of record on Monday, June 2nd will be given a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 0.40%. The ex-dividend date is Monday, June 2nd. McKesson's payout ratio is 10.99%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.